Skip to main content
Explore URMC
URMC / Alzheimers Care

AD-CARE: Alzheimer's Disease Care, Research and Education Program



The AD-CARE Program is encouraged by the recent FDA approval of Aduhelm (aducanumab). Details are still to come about the use of aducanumab in clinical practice. If you are interested in finding out more about how to access aducanumab through the University of Rochester, please visit:

Advancement of clinical research is a fundamental mission of the AD-CARE program.  We participate in a number of national and international studies that focus on different aspects of Alzheimer's Disease.

Specialists who have expertise in dementia treatment and research direct the day-to-day activities of our clinical studies.

We conduct studies concerning:

  • Prevention of Alzheimer's Disease
  • Early memory problems or cognitive impairment
  • Diagnostic tools used for Alzheimer's Disease
  • Behavioral disturbances in persons with Alzheimer's Disease



Forget-Me-Not Fund

Help support Alzheimer's Disease clinical research in the Rochester area by making a donation to the Forget-Me-Not Fund.